Please login (Members) to view content or
(Nonmembers) this article.
No votes yet
Update On…

Update on … Non-Small Cell Lung Cancer

Susan Weiss Behrend
ONF 2013, 40(5), 519-520 DOI: 10.1188/13.ONF.519-520

A study by Groth et al. (2013) identified the impact of insurance status on the delivery of definitive lobectomy for early-stage non-small cell lung cancer (NSCLC). One-fifth of an estimated 226,000 cases in 2012 presented with early-stage disease (Siegel, Naishadham, & Jemal, 2012). With appropriate therapy, five-year survival rates can exceed 65%, whereas, without prompt and aggressive intervention, five-year survival plummets to less than 5% (National Cancer Institute, 2010). Healthcare providers must offer access and optimal treatment to this patient population regardless of insurance status.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or